Yuying Feng
State Key Laboratory Of Biotherapy
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 02, 2025
Podocyte FFAR4 deficiency aggravated glomerular diseases and aging.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 22, 2025
Modification of RNF183 via m6A Methylation Mediates Podocyte Dysfunction in Diabetic Nephropathy by Regulating PKM2 Ubiquitination and Degradation.
Journal: Cells
Published: January 10, 2025
Structure, function and drug discovery of GPCR signaling.
Journal: Molecular biomedicine
Published: October 05, 2023
Ligand recognition and G-protein coupling of trace amine receptor TAAR1.
Journal: Nature
Published: June 08, 2023
Mechanism of activation and biased signaling in complement receptor C5aR1.
Journal: Cell research
Published: August 08, 2022
Blood purification for sepsis: an overview.
Journal: Precision clinical medicine
Published: December 31, 2020
Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy.
Journal: European journal of pharmacology
Published: August 17, 2020
Immunomodulatory role of recombinant human erythropoietin in acute kidney injury induced by crush syndrome via inhibition of the TLR4/NF-κB signaling pathway in macrophages.
Journal: Immunopharmacology and immunotoxicology
Published: January 24, 2020
Pharmacological and genetic inhibition of fatty acid-binding protein 4 alleviated cisplatin-induced acute kidney injury.
Journal: Journal of cellular and molecular medicine
Published: March 25, 2019
Last Updated: 09/26/2026